Insulet has gained the US Food and Drug Administration's (FDA) 510(k) approval for its new version of tubeless insulin pump. The new easy-to-use OmniPod insulin management system features the same 200-unit insulin reservoir capacity, ...
Tags: FDA, Insulet, tubeless insulin pump, clinical technology
Insulet, a provider of tubeless insulin pump technology, has reported a net loss of $12.42m, or $0.26 per share, for the third quarter ended 30 September 2012 compared to a net loss of $13.56m, or $0.29 per diluted share, for the third ...
Tags: Insulet, tubeless insulin pump technology, Financial situation